-
Who we are
Who we are
Novavax is a global biotechnology company with a proven vaccine technology. We are focused on developing our R&D assets and establishing partnerships to leverage the value of our technology to help protect health.
Discover our scienceLearn about our validated protein-based nanoparticle and Matrix-M™ adjuvant technology.
-
What we do
What we do
Novavax is focused on using our proven vaccine technology to help protect health through the development of our R&D assets and establishing partnerships
Latest UpdatesStay current with Novavax news as we make progress in discovering and developing innovative vaccines to help protect against serious infectious diseases.
-
Blog
Blog
Novavax is committed to accelerating the development of new and promising vaccines and sharing information based on years of study and experience.
What we do
Novavax is focused on using our proven vaccine technology to help protect health through the development of our R&D assets and establishing partnerships
Our approach to science
We are a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to help prevent serious infectious diseases.
Our proprietary protein vaccine platform and adjuvant technology can be applied to address current and emerging global health threats.
Recombinant nanoparticle vaccine technology
We are committed to delivering novel products that leverage cutting edge recombinant protein nanoparticles to protect against a broad range of infectious diseases.
Matrix-M™ adjuvant technology
Our saponin-based Matrix-M™ adjuvant enhances the immune response and has a dose-sparing effect, both of which are critical to successful vaccine development.